Second malignancies—risk reduction
- 31 December 1987
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 14 (3-4) , 337-343
- https://doi.org/10.1016/0305-7372(87)90027-2
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Zweittumoren nach zytostatischer Chemotherapie mit Alkylantien beim Menschen; toxikologische GesichtspunkteDeutsche Medizinische Wochenschrift (1946), 1986
- Noncarcinogenic chemotherapy with a combination of vincristine, methotrexate and 5-fluorouracil (VMF) in ratsInternational Journal of Cancer, 1983
- Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2′-dithio-bis-ethane sulfonate (dimesna)Cancer, 1983
- Occurrence of second tumors in man after anticancer drug treatmentCancer Treatment Reviews, 1982
- Carcinogenic activity in rats of combined treatment with cyclophosphamide, methotrexate and 5‐fluorouracilInternational Journal of Cancer, 1981
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976